Vimarsana
Biggest News Aggregation in the World

Davida Berry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Davida Berry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Davida Berry Today - Breaking & Trending Today

H.C. Wainwright Reaffirms Their Hold Rating on Axcella Health (AXLA) - Vimarsana News

H.C. Wainwright Reaffirms Their Hold Rating on Axcella Health (AXLA)

In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Axcella Health (AXLA – Research Report). The company&...

AXLA Stock Price | Axcella Health Inc. Stock Quote (U.S.: Nasdaq) - Vimarsana News

AXLA Stock Price | Axcella Health Inc. Stock Quote (U.S.: Nasdaq)

AXLA | Complete Axcella Health Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Seres Therapeutics (NASDAQ:MCRB) Stock Price Up 8.5% - Vimarsana News

Seres Therapeutics (NASDAQ:MCRB) Stock Price Up 8.5%

Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Rating)’s share price rose 8.5% on Tuesday . The company traded as high as $6.25 and last traded at $6.23. Approximately 1,791,792 shares traded hands during trading, a decline of 16% from the average daily volume of 2,130,646 shares. The stock had previously closed at $5.74. Wall Street Analyst […]

Eversept Partners LP Purchases 265,174 Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB) - Vimarsana News

Eversept Partners LP Purchases 265,174 Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB)

Eversept Partners LP increased its position in shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Rating) by 13.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,200,999 shares of the biotechnology company’s stock after acquiring an additional 265,174 shares during the quarter. Seres […]

Seres Therapeutics, Inc. (NASDAQ:MCRB) Receives Average Recommendation of "Moderate Buy" from Analysts - Vimarsana News

Seres Therapeutics, Inc. (NASDAQ:MCRB) Receives Average Recommendation of "Moderate Buy" from Analysts

Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Rating) has received an average rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The […]